Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.

CNS drugs - 1 Apr 2020

Elsayed Nada A, Yamamoto Kaila M, Froehlich Tanya E

Abstract excerpt

Multiple stimulant and non-stimulant medications are approved for the treatment of attention-deficit/hyperactivity disorder (ADHD), one of the most prevalent childhood neurodevelopmental disorders. Choosing among the available agents and determining the most effective ADHD medication for a given child can be a time-consuming process due to the high inter-individual variability in treatment efficacy. As a result,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention Deficit Disorder with Hyperactivity
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Pharmaceutical Preparations

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 32133580
DOI: 10.1007/s40263-020-00702-y
PMCID: PMC8083895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.PMID 32133580Read ↗

ADHD pharmacogenetics across the life cycle: New findings and perspectivesSemantic proximity Read ↗

Pharmacogenetic Approach for a Better Drug Treatment in ChildrenSemantic proximity Read ↗

Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.Semantic proximity Read ↗

Genetic risk factors and gene–environment interactions in adult and childhood attention-deficit/hyperactivity disorderSemantic proximity Read ↗

Pharmacogenetics of Methylphenidate Response in Preschoolers With ADHDSemantic proximity Read ↗

The Association with Quantitative Response to Attention-Deficit/Hyperactivity Disorder Medication of the Previously Identified Neurodevelopmental Network Genes.Semantic proximity Read ↗

Attention-deficit/hyperactivity disorder pharmacogenomics.Semantic proximity Read ↗

Genetics of attention-deficit/hyperactivity disorder: an update.Semantic proximity Read ↗

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.Semantic proximity Read ↗

Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in TreatmentSemantic proximity Read ↗

LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.